INSIGHTS ON DRUG DEVELOPMENT

• Overcoming Gene Therapy Cost Roadblocks On The Path To Patients

  Viral vector-based gene therapies are expanding beyond rare diseases to treat larger populations. Discover how innovations in manufacturing are making these life-changing treatments more accessible.

• Characterizing Binding Interactions By ITC

  Isothermal Titration Calorimetry is a powerful technique for analyzing biochemical binding events, which is crucial for understanding molecular interactions and enzyme kinetics in biomedical research.

• How Solid-State Characterization Shapes Drug Development

  Mark Benger, Site Director at Cambrex Edinburgh, on solid-state characterization as an insurance policy — front-loaded work that quietly determines whether a program survives the jump from kilos to tonnes.

• Integrated Stability Workflows That Reduce Manual Data Handling

  Integrated accelerated stability workflows reduce manual data handling while improving confidence in shelf‑life predictions. Help your teams move faster with fewer experimental demands.

• Aggregation In Antibody-Drug Conjugates: Causes And Mitigation

  9/1/2025

  Discover how early intervention in ADC development can streamline clinical progress, ensure stability and safety, and accelerate commercialization with expert guidance.

• 384-Well Microplate Time Resolved Fluorescence (TRF) Immunoassay

  9/18/2024

  Examine how innovative sandwich ELISAs in a 384-well format can be utilized with a sensitive reader for high-throughput screening to quantify Human IgG and IFN gamma.

• Streamlining Cell Line Development For Antibodies

  8/27/2025

  Streamline your antibody production with a robust Cell Line Development strategy. Discover how automation, analytics, and digital tools accelerate development from clone selection to commercialization.

• Take Action On PFAS To Protect Your Critical Processes

  9/18/2025

  PFAS restrictions are tightening, but a full ban could disrupt critical industries lacking alternatives, such as pharmaceutical manufacturing. Learn where PFAS use remains indispensable.

• Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency

  9/25/2025

  Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.